Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials
Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials
Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials
Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer
Short-term fasting linked to improved chemo response in advanced ovarian cancer
Aspirin use linked to improved survival in endometrial cancer
Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment
Zedoresertib plus lunresertib shows promising tumour shrinkage in CCNE1-amplified and FBXW7-mutant cancers
Reducing cancer burden through prevention
Raising awareness and increasing HPV vaccination coverage in Kazakhstan
Rebuilding trust in healthcare in historically marginalised communities
The role of nurses in strengthening cancer care in Africa
Addressing late presentation in cervical cancer through community awareness